OR WAIT null SECS
New survey will assess how pharma and biotech companies are incorporating patient engagement into their drug development organizations and operations.
The survey is very brief—it should take only 20-25 minutes to complete. All responses are confidential and will only be reported in the aggregate.
The survey can be found here.